Sector
PharmaceuticalsOpen
₹34,550Prev. Close
₹34,405Turnover(Lac.)
₹2,389.94Day's High
₹34,815Day's Low
₹33,20552 Week's High
₹37,00052 Week's Low
₹25,325Book Value
₹1,992.07Face Value
₹10Mkt Cap (₹ Cr.)
71,389.38P/E
50.58EPS
665.85Divi. Yield
1.41Sitagliptin has played a crucial role in managing type 2 diabetes by lowering HbA1c levels and improving blood sugar control.
Here are some of the stocks that may see significant price movement today: Jio Financial Service, Hero MotoCorp, Abbott India, etc.
The Board of Directors has recommended Final Dividend of ₹ 475 per equity share (of Face Value ₹10/- each) for the year ended March 31, 2025.
Here are some of the stocks that may see significant price movement today: JSW Energy, Abbott India, Patanjali Foods, etc.
EBITDA increased by 10.2% to ₹391.1 Crore in the first quarter of this fiscal year, up from ₹355 Crore the previous year.
Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
---|---|---|---|---|
Equity Capital | 21.25 | 21.25 | 21.25 | 21.25 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 4,211.9 | 3,677.64 | 3,167.29 | 2,798.54 |
Net Worth | 4,233.15 | 3,698.89 | 3,188.54 | 2,819.79 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 4,919.27 | 4,310.02 | 4,093.14 | 3,298.5 |
yoy growth (%) | 14.13 | 5.29 | 24.09 | 13.64 |
Raw materials | -2,657.21 | -2,390.92 | -2,315.65 | -1,904.74 |
As % of sales | 54.01 | 55.47 | 56.57 | 57.74 |
Employee costs | -579.46 | -492.65 | -476.1 | -393.69 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 1,079.73 | 925.95 | 802.69 | 621.48 |
Depreciation | -66.1 | -58.13 | -59.6 | -16.18 |
Tax paid | -281.03 | -235.26 | -209.75 | -220.26 |
Working capital | 201.35 | 142.23 | 751.83 | 336.01 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 14.13 | 5.29 | 24.09 | 13.64 |
Op profit growth | 18.04 | 21.81 | 44.22 | 32.01 |
EBIT growth | 16.37 | 16.39 | 29.73 | 42.59 |
Net profit growth | 15.63 | 16.48 | 47.78 | 45.02 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,706.7 | 95.71 | 4,09,218.58 | 753.53 | 0.94 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,595.5 | 79.35 | 1,75,226.52 | 667 | 0.45 | 2,536 | 561.08 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,741.9 | 63.7 | 1,26,637.21 | 551 | 0.16 | 2,567 | 224.34 |
Cipla Ltd CIPLA | 1,554.6 | 24.3 | 1,25,540.69 | 1,303.13 | 1.03 | 4,501.66 | 397.39 |
Dr Reddys Laboratories Ltd DRREDDY | 1,270.3 | 15.39 | 1,06,062.83 | 2,961.2 | 0.63 | 7,788.7 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman (Non-Executive)
Munir Shaikh
Non Executive Director
Kaiyomarz Marfatia
Non Executive Director
Ambati Venu
Independent Director
Anisha Motwani
Independent Director
Sudarshan Jain
Independent Director
Shalini Kamath
Non Executive Director
Alison Davies
Company Sec. & Compli. Officer
Sangeeta Shetty
Managing Director
Kartik Rajendran
Unit No 3 Corporate Park,
Sion Trombay Road Chembur,
Maharashtra - 400071
Tel: 91-22-67978888/50461000/2000/1119
Website: http://www.abbott.co.in
Email: investorrelations.india@abbott.com; webmaster@abbo
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@kfintech.com
Summary
Abbott India Limited was originally incorporated on August 22, 1944 as Boots Pure Drug Company (India) Limited. The company name was changed to The Boots Company (India) Limited on November 1, 1971, t...
Read More
Reports by Abbott India Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.